Chiara Ninfali

Chiara Ninfali is a Researcher leading the Biosensors for bioengineering group at the Institute for Bioengineering of Catalonia (IBEC). Her work focuses on integrating bioengineering principles with advanced biosensing technologies to address challenges in healthcare and regenerative medicine. Her research interests include the development of innovative biosensors, nanobioengineering applications, and the molecular mechanisms underlying muscle regeneration and inflammatory processes.

Her scientific contributions span interdisciplinary fields such as biomaterials, cellular engineering, and molecular oncology. She explores how transcription factors like ZEB1 regulate critical biological processes, including muscle atrophy, inflammation-driven carcinogenesis, and stem cell differentiation. Her studies utilize mouse models and human embryonic stem cells (hESCs) to uncover pathways with translational potential.

Chiara’s collaborative projects aim to bridge fundamental research with clinical applications, emphasizing translational bioengineering solutions. Her work has been published in high-impact journals, with recent studies addressing ZEB1’s role in atherosclerosis, mitochondrial function in macrophages, and fasting-induced muscle atrophy mechanisms.

Despite no explicit mention of awards in the text, her active research group and multiple publications reflect her contributions to bioengineering and molecular biology. Her lab’s focus on biosensors and regenerative therapies underscores her commitment to advancing healthcare technologies.